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Summary. PGE2 is essential for mammalian female
reproduction. This study was to examine the expression
of EP2 gene in the rat uterus during early pregnancy,
delayed implantation and artificial decidualization by in
situ hybridization and immunohistochemistry. There was
no detectable EP2 mRNA expression in the uterus from
days 1 to 4 of pregnancy (day 1 = day of vaginal sperm).
A low level of EP2 immunostaining was observed in the
luminal and glandular epithelium from days 1 to 4 of
pregnancy. Both EP2 mRNA and protein expression
were highly detected in the luminal epithelium at
implantation sites on day 6 of pregnancy. EP2
expression decreased from day 7 of pregnancy and was
undetectable on days 8 and 9 of pregnancy. After
delayed implantation was terminated by estrogen
treatment and the embryo implanted, both EP2 mRNA
and protein expression were strongly observed in the
luminal epithelium at the implantation site. There was no
detectable EP2 expression in both control and
decidualized uteri. In conclusion, these data suggest that
EP2 expression at implantation site may play an
important role during embryo implantation in rats.
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Introduction
Prostaglandins (PGs) consist of PGE2, PGF2α,
PGD2, PGI2 and TXA2 (Breyer et al., 2000). PGs are
involved in various functions, including the modulation
of vascular responses, cell proliferation and
differentiation. PGE2 is produced through three
sequential enzymatic reactions: release of arachidonic
acid (AA) from membrane glycerophospholipids by
phospholipase A2 (PLA2), conversion of AA to the
unstable intermediate PGH2 by cyclooxygenase (COX),
and enzymatic conversion of PGH2 to PGE2 by
prostaglandin E synthase (PGES) (Murakami et al.,
2002). PGE2 receptors are classified into four subtypes,
EP1, EP2 EP3 and EP4 according to their different
affinities for some relatively selective agonists
(Sugimoto et al., 2000). EP1 is coupled to Ca2+
mobilization, but both EP2 and EP4 subtypes are
coupled to the stimulation of adenylyl cyclase via Gs.
On the contrary, EP3 is coupled to Gi, which inhibits
adenylyl cyclase activity (Negishi et al., 1995).
PGs are shown to be important for implantation and
decidualization in laboratory rodents (Kennedy, 1994;
Lim et al., 1999). PGE2 is able to induce implantation of
mouse blastocysts (Holmes and Gordashko, 1980).
Among various PGs, PGE2 and prostacyclin (PGI2) havebeen considered as a primary candidate involved in
implantation and decidualization in the rodents (Lim et
al., 1999). EP2 mRNA expression was exclusively
localized in the luminal epithelium of mouse uterus
primarily during the peri-implantation period (Lim and
Dey, 1997). In the rat, PGI2 and PGE2 are higher in
implantation sites than in the surrounding uterus
(Kennedy, 1977; Kennedy and Zamecnik, 1978). EP2
expression was also examined in the pseudopregnant rat
uterus (Papay and Kennedy, 2000). 
However, the expression and regulation of the EP2
gene during the peri-implantation period in other species
are still unknown. The aim of the present study was to
examine the expression and regulation of EP2 in the rat
uterus during early pregnancy. In situ hybridization and
immunohistochemistry were used to examine the
expression of the EP2 gene in the rat uterus during early
pregnancy, delayed implantation and artificial
decidualization. 
Materials and methods
Animals and treatments
Mature rats (Sprague-Dawley strain) were caged in a
controlled environment with a 14 hr light: 10 hr dark
cycle. All animal procedures were approved by the
Institutional Animal Care and Use Committee of
Northeast Agricultural University. Adult females were
mated with fertile males of the same strain to induce
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pregnancy. Pregnancy was confirmed by examining the
spermatozoa in vaginal smear (day 1 = day of vaginal
sperm positive). Pregnancy on days 1-5 was confirmed
by flushing embryos from the reproductive tracts. The
implantation sites on days 6-7 were identified by
intravenous injection of 1 ml of 1% (w/v) Chicago blue
solution in 0.85% (w/v) NaCl 5 min before the rats were
sacrificed. At least 3 rats were used in each stage or
treatment in this study.
To induce delayed implantation, the pregnant rats on
day 4 of pregnancy were treated with progesterone (5
mg/rat, s.c.) and then ovariectomized at 0830-0900 h.
Progesterone (5 mg/rat) was injected to maintain delayed
implantation from days 5-7. Estradiol-17ß (250 ng/rat)
was given to the progesterone-primed delayed-
implantation rats to terminate delayed implantation. The
rats were killed by stunning and cervical dislocation to
collect uteri 24 h after estrogen treatment. The
implantation sites were identified by tail intravenous
injection of 1 ml of 1% (w/v) Chicago blue solution 5
min before the rats were sacrificed. 
In order to get artificial decidualization, mature
female rats were ovariectomized and sensitized for the
decidual cell reaction 5 days later according to the
procedures described previously (Kennedy and Ross,
1997). Some of the rats were given bilateral intrauterine
injection of 100 µl of sesame oil at 1200-1300 on the
equivalent of day 5 of pseudopregnancy. The animals
that did not receive the intrauterine injection served as
non-stimulated controls (Orlando-Mathur et al., 1996).
Treated rats were killed 6 days after the intrauterine
injection of oil.
Western blot
Rat liver, kidney and uterus on day 4 of pregnancy
were homogenized in pre-cooled homogenization buffer
(50 mM Tris-HCl, pH 7.5; 150 mM NaCl, 1% Triton X-
100, 0.25% sodium deoxycholate, 20 mg/ml
phenylmethanesulfonyl fluoride) and centrifuged at
12,000 g and 4°C for 10 min. The supernatants were
quantified for protein concentration, followed by SDS-
PAGE and electron transfer onto nitrocellulose
membrane. After being blocked in 5% nonfat milk in
PBST (0.1% Tween-20 in PBS) at 4°C overnight, the
membranes were incubated with rabbit anti-human EP2
antibody (1:800, Cayman Chemical, Ann Arbor, MI,
USA) for 1 h. Following 3 washes in 5% nonfat milk in
PBST, the membranes were incubated with goat anti-
rabbit IgG conjugated with horseradish peroxidase for 1
h. After 3 washes in 5% nonfat milk in PBST, 2 washes
in PBST, and 2 washes in PBS, the membranes were
incubated with ECL reagents, exposed and developed
according to the manufacturer’s protocol (Amersham
Pharmacia Biotech UK Limited, England, UK). 
Immunohistochemistry
Rat uteri were immediately fixed in Bouin’s solution
for 24 h and embedded in paraffin wax. Sections (7 µm)
were cut, deparaffinized and rehydrated. Antigen
retrieval was performed by incubating the sections in 0.1
mM EDTA (pH 9.0) at 88°C water bath for 10 min and
by cooling naturally at room temperature for 20 min.
Nonspecific binding was blocked in 10% (v/v) normal
horse serum in PBS for 1 h. The sections were incubated
with rabbit anti-human EP2 polyclonal antibody in 10%
(v/v) horse serum (1:100, Cayman) for 1 h overnight at
4°C. This antibody was shown to have a cross-reaction
with rat EP2 according to the instructions from the
company. The sections were then incubated with
biotinylated goat anti-rabbit antibody followed by an
avidin-alkaline phosphatase complex and Vector Red
(Vectastain ABC-AP kit, Vector Laboratories,
Burlingame, CA, USA). Vector Red was visualized as a
red color. Normal rabbit IgG was used to replace the
primary antibodies for a negative control. Endogenous
alkaline phosphatase activity was inhibited by
supplementing 1 mM levamisole (Sigma) into Vector
Red substrate solution. The sections were counterstained
with hematoxylin and mounted. The degree of staining
was assessed subjectively by blinded examination of the
slides by two investigators.
In situ hybridization
The following primers were designed based on the
mouse cDNA sequence (GenBank accession number
D50589), forward primer 5’-GATGCTCATGCT
CTTCGC and reverse primer: 5’-GAAGTCCG
ACAACAGAGG (from 523 to 1143 bp). A 621 bp
fragment was obtained by using these primers to amplify
the pcDNA3 plasmid containing rat EP2 cDNA (Kindly
provided by Dr. Kathy McCusker from Merck Frosst
Canada Inc., Canada). The amplified fragment (621 bp)
of rat EP2 was recovered from the agarose gel and
cloned into pGEM-T plasmid (pGEM-T Vector System
1, Promega). These plasmids were further amplified with
SP6 and T7 primers for labeling. Digoxigenin (DIG)-
labeled antisense or sense cRNA probes were
transcribed in vitro using a DIG RNA labeling kit
(Roche Diagnostics GmbH, Mannheim, Germany).
Uteri were cut into 4-6 mm pieces and flash frozen
in liquid nitrogen. Frozen sections (10 µ m) were
mounted on 3-aminopropyltriethoxy-silane (Sigma)-
coated slides and fixed in 4% paraformaldehyde solution
in PBS. In situ hybridization was performed as
previously described (Ni et al., 2002). Briefly, the
sections were incubated in the hybridization buffer (5 X
SSC, 50% formamide, 0.02% BSA, 250 µg/ml yeast
tRNA, 10% dextran sulfate, 1 µg/ml denatured DIG-
labeled antisense or sense RNA probe for rat EP2) at
55°C or 16 h. After hybridization, the sections were
washed in 50% formamide/5 X SSC, 50% formamide/2
X SSC, and 50% formamide/0.2 X SSC at 55°C twice
for 30 min each, respectively. After blocking in 1%
block mix (Roche) for 1 h, the sections were incubated
in sheep anti-DIG antibody conjugated with alkaline
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phosphatase (1:5000, Roche) in 1% block mix overnight
at 4°C. The signal was visualized with 5-bromo-4-
chloro-3-indolyl phosphate and nitroblue tetrazolium.
Endogenous alkaline phosphatase activity was inhibited
with 2 mM levamisole (Sigma). All of the sections were
counter-stained with 1% methyl green. 
Results
Western blot analysis
Western blot analysis was performed to detect EP2
protein in rat liver, kidney and uterus on day 4 of
pregnancy. A band at 53 kDa was seen in rat liver and
kidney. However, two bands were seen in the uterine
sample on day 4 of pregnancy, one at ~53 kDa, and
another one at ~50 kDa (Fig. 1). When rabbit anti-
human EP2 antibody was replaced with normal rabbit
IgG, the corresponding bands were not detected (data
not shown).
EP2 mRNA expression in rat uterus during early
pregnancy
There were no detectable EP2 mRNA signals in the
uteri from days 1 to 4 of pregnancy (Fig. 2A,B). A basal
level of EP2 mRNA expression was seen in the luminal
epithelium on day 5 of pregnancy. EP2 mRNA
expression was strongly localized in the luminal
epithelium at the implantation site on day 6 of pregnancy
(Fig. 2C), while no signal was seen at inter-implantation
areas. When DIG-labeled EP2 anti-sense probe was
replaced by DIG-labeled EP2 sense probe, there was no
detectable signal at the implantation site on day 6 of
pregnancy (Fig. 2D). On day 7 of pregnancy, EP2
mRNA signals were observed in the luminal epithelium
(Fig. 2E). However, there was no detectable EP2 mRNA
expression in the uteri from days 8 and 9 of pregnancy
(Fig. 2F,G). EP2 mRNA expression in the luminal
epithelium of rat uterus during early pregnancy was
summarized in Table 1.
EP2 immunostaining in rat uteri during early pregnancy
There was a low level of EP2 immunostaining in the
luminal and glandular epithelium on days 1 and 2 of
pregnancy (Fig. 3A). EP2 immunostaining slightly
increased in the luminal and glandular epithelium on
days 3-5 of pregnancy (Fig. 3B). At the implantation site
on day 6, a strong EP2 immunostaining was observed in
the luminal epithelium surrounding the implanting
blastocyst, while a low level of EP2 immunostaining
was seen in other areas of luminal epithelium (Fig. 3C).
After rabbit anti-human EP2 antibody was replaced by
normal rabbit IgG, there was no detectable
immunostaining at the implantation site on day 6 of
pregnancy (Fig. 3D). From days 7 to 9 of pregnancy,
there was no detectable EP2 immunostaining in the uteri
(Fig. 3E-G). EP2 protein expression in the luminal
epithelium of rat uterus during early pregnancy was
summarized in Table 1.
EP2 expression in the uterus under delayed implantation
and activation
There was no detectable EP2 mRNA signal in the
uterus under delayed implantation (Fig. 4A). After
delayed implantation was terminated by estrogen
treatment and embryo implanted, EP2 mRNA signal was
observed in the luminal epithelium at the implantation
site (Fig. 4B). Under delayed implantation, EP2
immunostaining was strongly detected in the luminal
and glandular epithelia (Fig. 4C). After delayed
implantation was terminated by estrogen treatment and
the embryo implanted, a strong level of EP2
immunostaining was only detected in the luminal
epithelium (Fig. 4D).
EP2 expression under artificial decidualization
There was no detectable EP2 mRNA signal in the
uterine horn for control (Fig. 4E). After decidualization
was artificially induced, EP2 mRNA signal was still not
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Fig. 1. Western blot analysis of EP2 protein in rat tissues. A band at 53
kDa was seen in rat liver and kidney. However, two bands were seen in
the uterine sample on day 4 of pregnancy, one at ~53 kDa, and another
one at ~50 kDa.
Table 1. EP2 expression in the luminal epithelium of rat uterus during
early pregnancy*
DAYS OF PREGNANCY
1 2 3 4 5 6(IS) 6(NIS) 7 8 9
EP2 mRNA - - - - - ++ - + - -
EP2 Protein + + + + + +++ + - - -
IS, implantation site; NIS, non-implantation site.
seen in the uterus (Fig. 4F). Although there was a basal
level of EP2 immunostaining in the luminal epithelium
in the control uterine horn (Fig. 4G), no EP2
immunostaining was seen in the uterus undergoing
artificial decidualization (Fig. 4H). 
Discussion
In our study, a band at ~53 kDa was seen in rat liver,
kidney and uterus, but a band at ~50 kDa was detected
only in the rat uterus. Because there were no detectable
bands after rabbit anti-human EP2 was replaced with
normal rabbit IgG, this antibody should be specific for
EP2. Additionally, rabbit anti-human EP2 antibody was
shown to have a cross-reaction with rat EP2 protein by
the supplier (Cayman). There are two transcripts of EP2
mRNA, uterine type and macrophage type. The
macrophage type EP2 mRNA was expressed in various
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Fig. 2. In situ
hybridization of
EP2 mRNA in
rat uterus on
days 1 (A), 4
(B), 6 (C), 7 (E),
8 (F), and 9 (G)
during early
pregnancy.
There was a
strong level of
EP2 mRNA
signals in the
luminal
epithelium on
days 6 (C) and
7 (E) of
pregnancy. After
EP2 antisense
probe was
replaced by EP2
sense probe, no
signals were
detected in the
uterus on day 6
(D). Arrow:
Embryos. Bar:
30 µm.
 
tissues, whereas the uterine EP2 mRNA was found only
in the uterus (Katsuyama et al., 1998). The band at ~53
kDa may be equivalent to macrophage type EP2, and the
band at ~50 kDa may be uterine EP2. 
There were apparent discrepancies between the in
situ hybridization and immunohistochemical data in our
study. Although there were no detectable EP2 mRNA
signals in the uteri on days 3 and 4 of pregnancy, and
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Fig. 3. Immunostaining of EP2 protein in rat uterus on days 1 (A), 4 (B), 6 (C), 7 (E), 8 (F), and 9 (G) during early pregnancy. EP2 immunostaining was
strongly detected in the luminal epithelium on day 6 of pregnancy (C). However, no immunostaining was seen after rabbit anti-EP2 IgG was replaced by
normal rabbit IgG (D). Arrow: Embryos. Bar: 25 µm. 
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Fig. 4. EP2
expression in rat
uterus under
delayed
implantation and
artificial
decidualization.
Under delayed
implantation, no
EP2 mRNA
signal was seen
(A), while EP2
immunostaining
was strongly
seen in the
luminal and
glandular
epithelia (C).
After delayed
implantation
was terminated
by estrogen
treatment and
the embryo
implanted, both
EP2 mRNA (B)
and
immunostaining
(D) were
evidently
observed in the
luminal
epithelium.
There was no
detectable EP2
mRNA signal in
the control
uterus (E) and
decidualized
uterus (F). A
basal level of
EP2
immunostaining
was seen in the
luminal
epithelium of
control uterus
(G), while no
EP2
immunostaining
was seen in the
decidualized
uterus (H).
Arrow:
implanting
blastocyst; *:
uterine lumen.
Bar: 25 µm. 
 
under delayed implantation, EP2 immunostaining was
obviously seen in the luminal and glandular epithelium
under these conditions. These discrepancies suggest that
the immunostaining method for detecting EP2 protein
may be more sensitive than in situ hybridization method
for showing EP2 mRNA. Furthermore, EP2 mRNA
expression was indeed demonstrated in mouse uteri from
days 1 to 4 of pregnancy and under delayed implantation
(Lim and Dey, 1997). 
EP2 expression in the rat uterus during early
pregnancy was examined in this study. Both EP2 mRNA
and immunostaining were highly expressed in the
luminal epithelium at implantation sites on day 6 of
pregnancy, but not detected or at a low level at inter-
implantation sites. In the mouse, EP2 mRNA is
expressed exclusively in the luminal epithelium
primarily on day 4 (the day of implantation) and day 5
(early implantation) of pregnancy (Lim and Dey, 1997).
In the pseudopregnant rat uterus, no specific EP2
expression were detected in any cell type on day 4 of
pseudopregnancy, while strong signals were detected
specifically in the luminal epithelium by day 5 of
pseudopregnancy (Papay and Kennedy, 2000). There
was no detectable EP2 mRNA signal in the rat uterus
under delayed implantation, but EP2 mRNA signal was
observed in the luminal epithelium at the implantation
site after activation. However, EP2 immunostaining in
the luminal epithelium was detected in the uteri both
under delayed implantation and after activation. In the
mouse, EP2 mRNA was present in the luminal
epithelium under delayed implantation and the
expression was further enhanced regardless of the
location of the blastocysts after reinitiation of
implantation (Lim and Dey, 1997). Because EP2
expression was detected in the mouse and rat uteri under
the progesterone-maintained delayed implantation, these
data may also suggest that EP2 expression in rodent uteri
may be under the regulation of progesterone and
estrogen. Indeed, in the adult ovariectomized mice,
estrogen down-regulated the basal levels of EP2 mRNA,
whereas progesterone up-regulated its levels in the
luminal epithelium. The up-regulation of EP2 mRNA
levels by progesterone was further augmented by
estrogen treatment (Lim and Dey, 1997). A tissue-
specific potential progesterone response element was
found in the 2 kb segment containing the immediate 5'-
flanking and 5'-noncoding regions of the EP2 gene in the
pseudopregnant mouse uterus, which is very different
from macrophage, suggesting that EP2 gene expression
in the macrophage and uterus may be under the control
of distinct mechanisms involving alternative promoters
(Katsuyama et al., 1998).
EP2 is highly expressed in the luminal epithelium of
rat and mouse uteri during the peri-implantation period,
suggesting that EP2 could be a potential mediator of
PGE2 actions in regulating luminal epithelialdifferentiation. Previous studies have shown that a de-
epitheliated stroma fails to decidualize after application
of a deciduogenic stimulus, suggesting that the stimulus
must transduce a “decidual” signal via the luminal
epithelium (Lejeune et al., 1981). PGE2 is able to restore
the endometrial vascular permeability response and
decidualization when infused into the lumen of
sensitized rat uteri in which endogenous PG synthesis is
inhibited (Hamilton and Kennedy, 1994). PGE2 also
exerts an immunomodulation that helps to prevent
rejection of the conceptus (Lala, 1990). Interferon-τ
(IFN-τ) is the recognized pregnancy recognition signal
produced by the embryo in ruminants, and in the bovine
it is produced maximally between days 15 and 19 of
pregnancy (Bartol et al., 1985). In bovine uterus, IFN-τ
increases EP2 in endometrial stroma and in smooth
muscle cells of myometrium (Arosh et al., 2004). 
In a study, EP2-deficient females yielded
significantly fewer implantation sites when mated to
either wild-type or EP2 null males as compared with the
wild-type females (Breyer et al., 2000). However, Hizaki
et al. (1999) found that there was no difference in the
ability of the mouse uterus to support implantation in
EP2-deficient females. It is possible that PGE2 may act
via an alternate receptor such as EP4 receptor to prevent
implantation defects in the EP2-deficient females
because both EP2 and EP4 subtypes are coupled to the
stimulation of adenylyl cyclase via Gs (Negishi et al.,
1995). In the rat, PGI2 and PGE2 are higher in
implantation sites than in the surrounding uterus
(Kennedy, 1977; Kennedy and Zamecnik, 1978). The
level of PGI2 at mouse implantation sites was the highest
followed by PGE2 and other prostanoids. In addition, the
level of PGE2 was significantly higher at the
implantation sites compared with the interimplantation
sites (Lim et al., 1999). PGE2 has a major role for
inducing implantation of mouse blastocysts (Holmes and
Gordashko, 1980). There are four isoforms of PGES for
the enzymatic conversion of PGH2 into PGE2, including
membrane-associated PGES (mPGES)-1, mPGES-2,
cytosolic PGES (cPGES) and GSTm (Murakami and
Kudo, 2004). Both mPGES-1 and cPGES were highly
expressed at implantation sites in the mouse uterus (Ni et
al., 2002, 2003). mPGES-1 is also highly expressed at
implantation sites in hamster uterus (Wang et al., 2004).
These data suggest that PGE2 produced in implantation
sites through the enzymatic conversion of PGES may
play an important role in implantation by acting through
EP2 receptor. However, COX-2-derived PGI2 is also
shown to be the primary PG that is essential for
implantation (Lim et al., 1999). It is possible that
implantation is mediated by both PGE2 and PGI2.
In conclusion, both EP2 mRNA and protein
expressions were strongly observed in the luminal
epithelium at the implantation site, suggesting that EP2
may play an important role during embryo implantation
in rats.
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